PB 45 of 2013

National Health (Continued Dispensing) Amendment Determination 2013 (No. 1)

 

National Health Act 1953

___________________________________________________________________________

 

 

I, Steve Dunlop, Acting Assistant Secretary, Pharmaceutical Access Branch, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health and Medical Research, make the following determination under subsection 89A(3) of the National Health Act 1953.

Dated   2 August  2013

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Steve Dunlop

Acting Assistant Secretary

Pharmaceutical Access Branch

Pharmaceutical Benefits Division

Department of Health and Ageing

___________________________________________________________________________

 

 

 

 

1 Name of Instrument

 

(1)                This Instrument is the National Health (Continued Dispensing) Amendment Instrument 2013 (No.1).

 

(2)                This Instrument may also be cited as PB 45 of 2013.

 

2       Commencement

This Instrument commences on the day after registration.

3 Amendments to National Health (Continued Dispensing) Determination 2012

Schedule 1 amends the National Health (Continued Dispensing) Determination 2012.

 

 

 

 

 

 

 

Schedule 1 Amendments

[1]       Subsection 1.03(2)

insert in alphabetical order:

 

[2]       after Paragraph 2.01(3)(b)

insert:

(c)  a reference to the pharmaceutical benefit in sections 2.03, 2.05, 2.06 and 2.07 includes a pharmaceutical benefit that is Schedule equivalent.

 

[3]       Section 3.01

omit:

3.01  Pharmaceutical benefits

For paragraph 89A (3) (a) of the Act, Schedule 1 sets out the pharmaceutical benefits that may be supplied by an approved pharmacist without a prescription for that supply under subsection 89A (1) of the Act.

insert:

3.01  Pharmaceutical benefits

(1)      For subsection 89A (3) (a) of the Act, an approved pharmacist may supply without a prescription a pharmaceutical benefit, being any listed brand of a pharmaceutical item mentioned in Schedule 1.

(2)      For subsection (1), the pharmaceutical item is the listed drug mentioned in Schedule 1:

(a) in the form mentioned in Schedule 1 for the listed drug; and

(b) with the manner of administration mentioned in Schedule 1 for the form of the listed drug.

 

[4]       Schedule 1

omit: 

 

insert:

Schedule 1 Pharmaceutical benefits

(sections 3.01)

Part 1 Oral hormonal contraceptives

Listed Drug

Form

Manner of Administration

Levonorgestrel

Tablets 30 micrograms, 28

Oral

Levonorgestrel with Ethinyloestradiol

Pack containing 21 tablets 100 micrograms-20 micrograms and 7 inert tablets

Oral

 

Pack containing 21 tablets 125 micrograms50 micrograms and 7 inert tablets

Oral

 

Pack containing 21 tablets 150 micrograms30 micrograms and 7 inert tablets

Oral

 

Pack containing 6 tablets 50 micrograms30 micrograms, 5 tablets 75 micrograms40 micrograms, 10 tablets 125 micrograms30 micrograms and 7 inert tablets

Oral

Norethisterone

Tablets 350 micrograms, 28

Oral

Norethisterone with Ethinyloestradiol

Pack containing 21 tablets 500 micrograms35 micrograms and 7 inert tablets

Oral

 

Pack containing 21 tablets 1 mg35 micrograms and 7 inert tablets

Oral

 

Pack containing 12 tablets 500 micrograms35 micrograms, 9 tablets 1 mg35 micrograms and 7 inert tablets

Oral

Norethisterone with Mestranol

Pack containing 21 tablets 1 mg50 micrograms and 7 inert tablets

Oral

 

 

 

 

 

 

Part 2 Lipid modifying agents

Listed Drug

Form

Manner of Administration

Atorvastatin

Tablet 10 mg (as calcium)

Oral

 

Tablet 20 mg (as calcium)

Oral

 

Tablet 40 mg (as calcium)

Oral

 

Tablet 80 mg (as calcium)

Oral

Fluvastatin

Capsule 20 mg (as sodium)

Oral

 

Capsule 40 mg (as sodium)

Oral

 

Tablet (prolonged release) 80 mg (as sodium)

Oral

Pravastatin

Tablet containing pravastatin sodium 10 mg

Oral

 

Tablet containing pravastatin sodium 20 mg

Oral

 

Tablet containing pravastatin sodium 40 mg

Oral

 

Tablet containing pravastatin sodium 80 mg

Oral

Rosuvastatin

Tablet 5 mg (as calcium)

Oral

 

Tablet 10 mg (as calcium)

Oral

 

Tablet 20 mg (as calcium)

Oral

 

Tablet 40 mg (as calcium)

Oral

Simvastatin

Tablet 5 mg

Oral

 

Tablet 10 mg

Oral

 

Tablet 20 mg

Oral

 

Tablet 40 mg

Oral

 

Tablet 80 mg

Oral

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Note

All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003.  See http://www.frli.gov.au.